Director Shareholding
GlaxoSmithKline PLC
5 January 2001
Directors' Interests in GlaxoSmithKline plc Ordinary Shares
I give below details of the directors' interests in the Ordinary Shares
('Shares') and American Depositary Shares (which represent two Shares)
('ADSs') of GlaxoSmithKline plc ('the Company') as of the commencement of
trading of the Company :
Name of director Number of Total holdings as a % of share Notes
Shares class
Sir Richard Sykes 538,665 0.00866 a
Sir Roger Hurn 10,539 0.00017
Sir Peter Walters 31,398 0.00050
Dr Jean-Pierre 105,694 0.00170 b
Garnier
John Coombe 164,203 0.00264 c
Paul Allaire 12,830 0.00021 b
Michele Barzach 812 0.00001
Derek Bonham 8,445 0.00014
Sir Christopher Hogg 5,121 0.00008
Peter Job 2,003 0.00003
John McArthur 7,116 0.00011 b
Donald McHenry 12,080 0.00019 b
Sir Ian Prosser 2,315 0.00004
Dr Ronaldo Schmitz 7,504 0.00012 b
Dr Lucy Shapiro 3,697 0.00006 d
John Young 19,650 0.00032 d
Notes:
a. Includes a non-beneficial interest in a trust which holds 36,612
Shares.
b. Shares held as ADSs.
c. Includes a non-beneficial interest in a trust which holds 20,397
Shares.
d. Includes Shares and ADSs.
The following directors have interests in Shares arising from the grant of
options under Glaxo Wellcome plc share option plans:
Name of Number of Shares Exercise Earliest date Expiry
director over which options price from which options date
are held £ are exercisable
Sir 92,236 16.10 27/12/2000 03/02/2003
Richard
Sykes 542,465 14.60 27/12/2000 24/08/2003
248 (SAYE) 13.27 27/12/2000 30/06/2001
John 41,739 16.10 27/12/2000 03/08/2009
Coombe
245,479 14.60 25/02/2003 24/02/2010
730 (SAYE) 13.27 1/12/2002 31/05/2003
The following director has an interest in ADSs arising from the grant of
options under SmithKline Beecham plc share option plans:
Name of Number of ADSs Exercise Earliest date Expiry
director over which options price from which options date
are held $ are exercisable
Dr 77,370 12.892091 24/11/1996 23/11/2003
Jean-Pierre
Garnier
28,582 12.870518 31/05/1997 30/05/2004
163,161 16.087083 20/07/1997 19/07/2004
231,052 14.530536 22/11/1997 21/11/2004
79,054 22.067443 15/11/1998 14/11/2005
68,411 28.159051 21/11/1999 20/11/2006
68,411 32.086995 24/03/2000 23/03/2007
225,324 40.536028 23/05/2000 12/11/2007
225,324 54.481547 23/05/2000 22/11/2008
341,400 61.353251 23/05/2000 14/03/2009
566,724 60.307557 23/05/2000 23/11/2009
The following directors have an interest in the Company's Shares arising from
Awards made under the Glaxo Wellcome Long Term Incentive Plan:
Name of director Number of Shares Award date Release date
Sir Richard Sykes 56,519 12/03/1998 31/12/2000
39,969 24/03/1999 31/12/2000
50,856 25/02/2000 31/12/2000
John Coombe 25,120 12/03/1998 12/03/2001
18,087 24/03/1999 24/03/2002
23,013 25/02/2000 25/02/2003
The following director has an interest in the Company's ADSs arising from
Awards made under the SmithKline Beecham Mid-Term Incentive Plan:
Name of Number of Grant Award Deferred until
director ADSs over date date (a)
which interest
is held
Dr Jean-Pierre 18,891 07/06/1996 15/03/1999 Deferred until
Garnier 15/03/2002
18,891 21/11/1996 09/03/2000 Deferred until
09/03/2003
18,891 24/03/1997 09/03/2000 Deferred until
09/03/2003
18,891 13/11/1997 31/12/2000 -
36,985 23/11/1998 31/12/2001 -
36,985 24/11/1999 31/12/2002 -
Note:
(a) After the grant has vested on the award date, the director may
elect to defer receipt of the award for a three year period or until
retirement.
S M Bicknell
Company Secretary
5th January 2001